Faculty:Faculty of Medical Science
Department:School of Medicine
Sarah is a Senior Lecturer in Pharmacology and has a special interest in active learning styles in undergraduate medical curriculums, particularly in the themes of physiology and pharmacology.
Sarah graduated in BSc Applied Physiology and Pharmacology from the University of the West of England, Bristol in 2005. In 2009, she received an MPhil in molecular epidemiology at Southampton University, where she was a medical demonstrator, before joining the Physiology teaching team at Keele University Medical School as an Associate Teaching Fellow where she gained her PGCert Higher Education and PGDip Medical Education. She went on to complete a PhD in Sport and Genetics at Manchester Metropolitan University. Here with the support of Sports Genomics Laboratory, MMU she worked alongside London Marathon to recruit the largest cohort of Caucasian national and international marathon runners for her research into the genetics of human performance. She joined Newcastle University School of Medicine in 2015 as a Teaching Fellow in Pharmacology and went on to co-lead the Clinical Pharmacology Therapeutics and Prescribing strand. Sarah joined the School of Medicine at Anglia Ruskin University, Chelmsford as the academic lead for Pharmacology in 2018. Sarah has a keen interest in Undergraduate Medical Education, particularly active learning styles in the areas of Physiology and Pharmacology. She was appointed a fellow of the Higher Education Academy in 2016, a Fellow of the Staff and Educational Development Association in 2012 and has been a member of ASME since 2011.
Elite endurance athletes tend to have differing genetic profiles from less successful athletes and non-athletes. Developing knowledge in this area, providing a more detailed analysis of the genetic constitution of elite marathon athletes than that done previously and identifying an ‘advantageous’ genetic profile in elite marathon athletes would be a significant development. The insight provided about the underlying physiological mechanisms has implications for both sport and also exercise for the prevention and treatment of disease.
Previously co-supervised four post-graduate research students.
Sarah’s primary teaching and learning roles are the co-ordination and delivery of the undergraduate pharmacology content to MBChB students at Anglia Ruskin University School of Medicine. Now focusing on Medical education, Sarah continues to ensure learning is underpinned with theoretical insights from the literature. She has experience of delivery on traditional, integrated and PBL based medical curriculums. Sarah is also a personal tutor providing academic and pastoral support to MBChB students in pre-clinical years.
Stebbings GK, Williams AG, Herbert AJ, Lockey SJ, Heffernan SM, Erskine RM, Morse CI, Day SH. (2018). TTN genotype is associated with fascicle length and marathon running performance. Scand J Med Sci Sports.28:400–406. http://doi.org/10.1111/sms.12927
Stebbings GK, Williams AG, Herbert AJ, Lockey SJ, Heffernan SM, Erskine RM, Morse CI, Day SH. Titin genotype is associated with skeletal muscle fascicle length in recreationally active men and running performance in habitually trained marathon runners. British Journal of Sports Medicine 50:1. http://dx.doi.org/10.1136/bjsports-2016-097120.96
Heffernan SM, Kilduff LP, Erskine RM, Day SH, McPhee JS, McMahon GE, Stebbings GK, Neale JP, Lockey SJ, Ribbans WJ, Cook CJ, Vance B, Raleigh SM, Roberts C, Bennett MA, Wang G, Collins M, Pitsiladis YP, Williams AG. Mar 2016. Association of ACTN3 R577X but not ACE I/D gene variants with elite rugby union player status and playing position. Physiol Genomics. 48(3):196-201. https://doi.org/10.1152/physiolgenomics.00107.2015
Seth-Smith HM, Harris SR, Persson K, Marsh P, Barron A, Bignell A, Bjartling C, Clarke L, Cutcliffe LT, Lambden PR, Lennard N, Lockey SJ, Quail MA, Salim O, Skilton RJ, Wang Y, Holland MJ, Parkhill J, Thomson NR, Clarke IN. 2009. Co-evolution of genomes and plasmids within Chlamydia trachomatis and the emergence in Sweden of a new variant strain. BMC Genomics 10: 239
Thomson NR, Holden MT, Carder M, Lennard N, Lockey SJ, Marsh P, Skipp P, O'Connor CD, Goodhead I, Norbertzcak H, Harris B, Ormond D, Rance R, Quail MA, Parkhill J, Stephens RS, Clarke IN. 2007. Chlamydia trachomatis: Genome sequence analysis of lymphogranuloma venereum isolates. Genome Research 18, 161-171